21 – 30 of 1017
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Decoding immune heterogeneity in bladder cancer : From cellular cartography to ex vivo models and antibody-based targeting
(2025)
- Thesis › Doctoral thesis (compilation)
-
Mark
Biomarkers for the Early Detection of Pancreatic Ductal Adenocarcinoma
(2025) p.85-100
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia
(2025) In Nature Cancer
- Contribution to journal › Article
-
Mark
Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation
- Contribution to journal › Article
-
Mark
ATOR-4066, a bispecific antibody targeting CD40 and CEACAM5, induces strong myeloid and T cell-dependent tumor immunity and synergizes with PD-1 blockade
(2025) In Cancer immunology research
- Contribution to journal › Article
-
Mark
Antisense-mediated regulation of exon usage in the elastic spring region of Titin modulates sarcomere function
- Contribution to journal › Article
-
Mark
The Carba Mix—In Vitro Investigations of Potential Cocktail Effects in Patch Tests With Rubber Allergens
- Contribution to journal › Article
-
Mark
Dual targeting of G9a and DNMTs induces antitumor effects in multiple myeloma
- Contribution to journal › Article
-
Mark
REACtiVe-2 : phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer
- Contribution to journal › Article
-
Mark
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer : Biomarkers associated with outcomes from OPTIMIZE-1
- Contribution to journal › Article
